Annual CFI
$95.09 M
+$37.42 M+64.90%
31 December 2023
Summary:
Athira Pharma annual cash flow from investing activities is currently $95.09 million, with the most recent change of +$37.42 million (+64.90%) on 31 December 2023. During the last 3 years, it has risen by +$305.16 million (+145.27%). ATHA annual CFI is now at all-time high.ATHA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$18.04 M
-$8.52 M-32.09%
30 September 2024
Summary:
Athira Pharma quarterly cash flow from investing activities is currently $18.04 million, with the most recent change of -$8.52 million (-32.09%) on 30 September 2024. Over the past year, it has dropped by -$2.65 million (-12.81%). ATHA quarterly CFI is now -49.22% below its all-time high of $35.52 million, reached on 31 March 2023.ATHA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$64.03 M
-$2.65 M-3.98%
30 September 2024
Summary:
Athira Pharma TTM cash flow from investing activities is currently $64.03 million, with the most recent change of -$2.65 million (-3.98%) on 30 September 2024. Over the past year, it has dropped by -$49.31 million (-43.51%). ATHA TTM CFI is now -43.51% below its all-time high of $113.34 million, reached on 30 September 2023.ATHA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.9% | -12.8% | -43.5% |
| 3 y3 years | +145.3% | +227.0% | +145.3% |
| 5 y5 years | +4637.9% | - | - |
ATHA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +145.3% | -49.2% | +227.0% | -43.5% | +145.3% |
| 5 y | 5 years | at high | +145.3% | -49.2% | +115.6% | -43.5% | +127.5% |
| alltime | all time | at high | +145.3% | -49.2% | +115.6% | -43.5% | +127.5% |
Athira Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $18.04 M(-32.1%) | $64.03 M(-4.0%) |
| June 2024 | - | $26.56 M(+103.7%) | $66.68 M(-8.2%) |
| Mar 2024 | - | $13.04 M(+104.1%) | $72.61 M(-23.6%) |
| Dec 2023 | $95.09 M(+64.9%) | $6.39 M(-69.1%) | $95.09 M(-16.1%) |
| Sept 2023 | - | $20.69 M(-36.3%) | $113.34 M(+6.6%) |
| June 2023 | - | $32.49 M(-8.5%) | $106.29 M(+53.3%) |
| Mar 2023 | - | $35.52 M(+44.1%) | $69.34 M(+20.2%) |
| Dec 2022 | $57.66 M | $24.65 M(+80.8%) | $57.66 M(+6.0%) |
| Sept 2022 | - | $13.63 M(-405.6%) | $54.39 M(+104.8%) |
| June 2022 | - | -$4.46 M(-118.7%) | $26.56 M(-37.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $23.85 M(+11.6%) | $42.48 M(-1141.3%) |
| Dec 2021 | -$4.08 M(-98.1%) | $21.37 M(-250.5%) | -$4.08 M(-97.1%) |
| Sept 2021 | - | -$14.20 M(-224.0%) | -$141.21 M(-36.2%) |
| June 2021 | - | $11.46 M(-150.4%) | -$221.32 M(-4.9%) |
| Mar 2021 | - | -$22.71 M(-80.4%) | -$232.78 M(+10.8%) |
| Dec 2020 | -$210.07 M(<-9900.0%) | -$115.76 M(+22.7%) | -$210.07 M(+122.7%) |
| Sept 2020 | - | -$94.31 M(<-9900.0%) | -$94.31 M(<-9900.0%) |
| June 2020 | - | $2000.00(+100.0%) | $3000.00(+200.0%) |
| Mar 2020 | - | $1000.00 | $1000.00 |
| Dec 2019 | $1.51 M(-25.0%) | - | - |
| Dec 2018 | $2.01 M | - | - |
FAQ
- What is Athira Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Athira Pharma?
- What is Athira Pharma annual CFI year-on-year change?
- What is Athira Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Athira Pharma?
- What is Athira Pharma quarterly CFI year-on-year change?
- What is Athira Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Athira Pharma?
- What is Athira Pharma TTM CFI year-on-year change?
What is Athira Pharma annual cash flow from investing activities?
The current annual CFI of ATHA is $95.09 M
What is the all time high annual CFI for Athira Pharma?
Athira Pharma all-time high annual cash flow from investing activities is $95.09 M
What is Athira Pharma annual CFI year-on-year change?
Over the past year, ATHA annual cash flow from investing activities has changed by +$37.42 M (+64.90%)
What is Athira Pharma quarterly cash flow from investing activities?
The current quarterly CFI of ATHA is $18.04 M
What is the all time high quarterly CFI for Athira Pharma?
Athira Pharma all-time high quarterly cash flow from investing activities is $35.52 M
What is Athira Pharma quarterly CFI year-on-year change?
Over the past year, ATHA quarterly cash flow from investing activities has changed by -$2.65 M (-12.81%)
What is Athira Pharma TTM cash flow from investing activities?
The current TTM CFI of ATHA is $64.03 M
What is the all time high TTM CFI for Athira Pharma?
Athira Pharma all-time high TTM cash flow from investing activities is $113.34 M
What is Athira Pharma TTM CFI year-on-year change?
Over the past year, ATHA TTM cash flow from investing activities has changed by -$49.31 M (-43.51%)